5 Best Small-Cap Healthcare Stocks to Buy According to Hedge Funds

4. Ocular Therapeutix Inc. (NASDAQ:OCUL)

Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the 7 best small-cap healthcare stocks to buy according to hedge funds.

On March 3, Tazeen Ahmad from Bank of America Securities increased the price target on Ocular Therapeutix Inc. (NASDAQ:OCUL) from $24 to $27 while maintaining a Buy rating on the stock. This results in a revised upside potential of more than 257% for investors.

According to Ahmad, a thorough examination of the Phase 3 SOL1 trial results offers compelling evidence in favour of the approval and risk reduction that the diabetic retinopathy program offers through clarifying important questions.

On March 3, Clear Street raised its price target on Ocular Therapeutix Inc. (NASDAQ:OCUL) from $21 to $28. The firm maintained its Buy rating on the shares. Clear Street cited positive data from the SOL-1 trial, noting the results support Axpaxli’s potential to deliver durable control in wet AMD.

Clear Street added that the therapy could address a key unmet need around dosing intervals, with strong efficacy and a favorable safety profile supporting a more constructive outlook.

Ocular Therapeutix Inc. (NASDAQ:OCUL) focuses on developing and commercializing therapeutics for different eye conditions, including retinal diseases, using its bioresorbable hydrogel-based formulation technology. Its portfolio includes DEXTENZA, AXPAXLI in phase 3 of clinical trial, and OTX-TIC in phase 2 of clinical trial.